NL9002008A - Recombinant dna en rna en daarvan afgeleide produkten. - Google Patents

Recombinant dna en rna en daarvan afgeleide produkten. Download PDF

Info

Publication number
NL9002008A
NL9002008A NL9002008A NL9002008A NL9002008A NL 9002008 A NL9002008 A NL 9002008A NL 9002008 A NL9002008 A NL 9002008A NL 9002008 A NL9002008 A NL 9002008A NL 9002008 A NL9002008 A NL 9002008A
Authority
NL
Netherlands
Prior art keywords
cav
protein
dna
genetic information
nucleotide sequence
Prior art date
Application number
NL9002008A
Other languages
English (en)
Dutch (nl)
Original Assignee
Stichting Centr Diergeneeskund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Centr Diergeneeskund filed Critical Stichting Centr Diergeneeskund
Priority to NL9002008A priority Critical patent/NL9002008A/nl
Priority to ZA917065A priority patent/ZA917065B/xx
Priority to IL99435A priority patent/IL99435A/en
Priority to JP3517451A priority patent/JP2846116B2/ja
Priority to US08/030,335 priority patent/US5491073A/en
Priority to EP91917088A priority patent/EP0548234B1/de
Priority to EP98202968A priority patent/EP0905246A1/de
Priority to SI9111508A priority patent/SI9111508B/sl
Priority to DK91917088T priority patent/DK0548234T3/da
Priority to ES91917088T priority patent/ES2144399T3/es
Priority to UA93004515A priority patent/UA48936C2/uk
Priority to YU150891A priority patent/YU49095B/sh
Priority to AU86580/91A priority patent/AU651999B2/en
Priority to RU93005170A priority patent/RU2146292C1/ru
Priority to DE69131903T priority patent/DE69131903T2/de
Priority to HU9300716A priority patent/HU220102B/hu
Priority to CA002091181A priority patent/CA2091181C/en
Priority to AT91917088T priority patent/ATE188739T1/de
Priority to PCT/NL1991/000165 priority patent/WO1992004446A1/en
Priority to MX9101042A priority patent/MX9101042A/es
Publication of NL9002008A publication Critical patent/NL9002008A/nl
Priority to US08/454,121 priority patent/US6071520A/en
Priority to HR940668A priority patent/HRP940668B1/xx
Priority to US08/484,939 priority patent/US6319693B1/en
Priority to US08/480,020 priority patent/US5932476A/en
Priority to US08/485,001 priority patent/US5981502A/en
Priority to US08/482,161 priority patent/US6162461A/en
Priority to US08/489,666 priority patent/US5922600A/en
Priority to US08/910,322 priority patent/US6238669B1/en
Priority to US08/910,618 priority patent/US5958424A/en
Priority to US09/057,963 priority patent/US6217870B1/en
Priority to US09/384,472 priority patent/US6509446B2/en
Priority to GR20000400866T priority patent/GR3033173T3/el
Priority to US09/740,676 priority patent/US7427658B2/en
Priority to US11/238,653 priority patent/US20060073160A1/en
Priority to US11/888,039 priority patent/US20080234466A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
NL9002008A 1990-09-12 1990-09-12 Recombinant dna en rna en daarvan afgeleide produkten. NL9002008A (nl)

Priority Applications (35)

Application Number Priority Date Filing Date Title
NL9002008A NL9002008A (nl) 1990-09-12 1990-09-12 Recombinant dna en rna en daarvan afgeleide produkten.
ZA917065A ZA917065B (en) 1990-09-12 1991-09-05 Recombinant dna and rna and products derived therefrom
IL99435A IL99435A (en) 1990-09-12 1991-09-06 Recombinant dna and rna and products derived therefrom
AT91917088T ATE188739T1 (de) 1990-09-12 1991-09-11 Klonierung hühner-anaemia-virus-dna
AU86580/91A AU651999B2 (en) 1990-09-12 1991-09-11 Cloning of chicken anaemia DNA
EP91917088A EP0548234B1 (de) 1990-09-12 1991-09-11 Klonierung hühner-anaemia-virus-dna
EP98202968A EP0905246A1 (de) 1990-09-12 1991-09-11 Klonierung Hühner-Anaemia-Virus-DNA
SI9111508A SI9111508B (en) 1990-09-12 1991-09-11 Recombinant DNA and RNA and products derived therefrom
DK91917088T DK0548234T3 (da) 1990-09-12 1991-09-11 Kloning af kyllingeanæmivirus DNA
ES91917088T ES2144399T3 (es) 1990-09-12 1991-09-11 Clonado del adn de virus de anemia de los pollos.
UA93004515A UA48936C2 (uk) 1990-09-12 1991-09-11 Спосіб одержання вірусу курячої анемії (cav) у дволанцюговій формі, рекомбінантна нуклеїнова кислота (варіанти), діагностичний набір (варіанти), вакцинний препарат (варіанти), культура клітин (варіанти), спосіб одержання діагностичного набору (варіанти)
YU150891A YU49095B (sh) 1990-09-12 1991-09-11 Rekombinantna dnk i rnk i proizvodi dobijeni od njih
US08/030,335 US5491073A (en) 1990-09-12 1991-09-11 Cloning of chicken anaemia DNA
RU93005170A RU2146292C1 (ru) 1990-09-12 1991-09-11 Последовательность днк, гибридизационная проба, олигонуклеотид (варианты), вакцины, cav-белок (варианты), диагностические наборы и штамм e.coli
DE69131903T DE69131903T2 (de) 1990-09-12 1991-09-11 Klonierung hühner-anaemia-virus-dna
HU9300716A HU220102B (hu) 1990-09-12 1991-09-11 Csirkeanémiavírus-DNS, klónozása és alkalmazásai
CA002091181A CA2091181C (en) 1990-09-12 1991-09-11 Cloning of chicken anaemia dna
JP3517451A JP2846116B2 (ja) 1990-09-12 1991-09-11 鶏貧血症ウィルス（ｃａｖ）組換え核酸、それを含むｃａｖ診断キット、および原核細胞または真核細胞、ならびにｃａｖ２本鎖ｄｎａの製造方法
PCT/NL1991/000165 WO1992004446A1 (en) 1990-09-12 1991-09-11 Cloning of chicken anaemia dna
MX9101042A MX9101042A (es) 1990-09-12 1991-09-11 Adn y arn recombinantes y productos derivados de los mismos
US08/454,121 US6071520A (en) 1990-09-12 1994-07-19 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
HR940668A HRP940668B1 (en) 1990-09-12 1994-10-12 Recombinant dna and rna and products derived therefrom
US08/484,939 US6319693B1 (en) 1990-09-12 1995-06-07 Cloning of chicken anemia virus DNA
US08/480,020 US5932476A (en) 1990-09-12 1995-06-07 Cloning of chicken anemia virus DNA
US08/485,001 US5981502A (en) 1990-09-12 1995-06-07 Methods and compositions for inducing apoptosis in tumor cells
US08/482,161 US6162461A (en) 1990-09-12 1995-06-07 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
US08/489,666 US5922600A (en) 1990-09-12 1995-06-07 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US08/910,618 US5958424A (en) 1990-09-12 1997-08-13 Recombinant chicken anemia virus particle
US08/910,322 US6238669B1 (en) 1990-09-12 1997-08-13 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins
US09/057,963 US6217870B1 (en) 1990-09-12 1998-04-09 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US09/384,472 US6509446B2 (en) 1990-09-12 1999-08-27 Cloning of chicken anemia DNA
GR20000400866T GR3033173T3 (en) 1990-09-12 2000-04-07 Cloning of chicken anaemia dna.
US09/740,676 US7427658B2 (en) 1990-09-12 2000-12-18 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
US11/238,653 US20060073160A1 (en) 1990-09-12 2005-09-28 Cloning of chicken anemia virus DNA
US11/888,039 US20080234466A1 (en) 1990-09-12 2007-07-30 Delivery method for the tumor-specific apoptosis-inducing activity of apoptin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9002008 1990-09-12
NL9002008A NL9002008A (nl) 1990-09-12 1990-09-12 Recombinant dna en rna en daarvan afgeleide produkten.

Publications (1)

Publication Number Publication Date
NL9002008A true NL9002008A (nl) 1992-04-01

Family

ID=19857669

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9002008A NL9002008A (nl) 1990-09-12 1990-09-12 Recombinant dna en rna en daarvan afgeleide produkten.

Country Status (21)

Country Link
US (6) US5491073A (de)
EP (2) EP0905246A1 (de)
JP (1) JP2846116B2 (de)
AT (1) ATE188739T1 (de)
AU (1) AU651999B2 (de)
CA (1) CA2091181C (de)
DE (1) DE69131903T2 (de)
DK (1) DK0548234T3 (de)
ES (1) ES2144399T3 (de)
GR (1) GR3033173T3 (de)
HR (1) HRP940668B1 (de)
HU (1) HU220102B (de)
IL (1) IL99435A (de)
MX (1) MX9101042A (de)
NL (1) NL9002008A (de)
RU (1) RU2146292C1 (de)
SI (1) SI9111508B (de)
UA (1) UA48936C2 (de)
WO (1) WO1992004446A1 (de)
YU (1) YU49095B (de)
ZA (1) ZA917065B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020061296A1 (en) * 2000-09-08 2002-05-23 Noteborn Mathieu H.M. Delivery method for the tumor specific apoptosis inducing activity of apoptin
NL9301272A (nl) * 1993-07-20 1995-02-16 Aesculaap Bv Chicken Anemia Virus mutanten en vaccins en toepassingen gebaseerd op de virale eiwitten VP1, VP2 en VP3 of daarvoor coderende sequenties van dat virus.
US20080234466A1 (en) * 1990-09-12 2008-09-25 Noteborn Mathieu H M Delivery method for the tumor-specific apoptosis-inducing activity of apoptin
US6162461A (en) * 1990-09-12 2000-12-19 Leadd B.V. Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
US20030138443A1 (en) * 1993-03-08 2003-07-24 Noteborn Mathews H.M. Cloning of chicken anemia virus DNA
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic
EP0878546A1 (de) * 1997-04-15 1998-11-18 Leadd B.V. Genabgabe-Vehikel die das Apoptosis VP2 inducierendes Protein, und/oder Apoptin exprimiert
US5789567A (en) * 1994-07-06 1998-08-04 Cornell Research Foundation, Inc. Chicken infectious anemia virus vaccine
GB9414888D0 (en) * 1994-07-23 1994-09-14 Univ Belfast Method and composition
AU720640B2 (en) * 1995-06-07 2000-06-08 Leadd B.V. Neutralizing conformational epitopes of chicken anemia virus
WO1997018329A1 (en) * 1995-11-14 1997-05-22 Ragland William L Efficient method of detecting an infectious agent in blood
CA2301401C (en) 1997-08-12 2008-10-21 Leadd B.V. Determining the transforming capability of agents
US6287856B1 (en) * 1998-03-13 2001-09-11 University Of Georgia Research Foundation, Inc. Vaccines against circovirus infections
PT1083224E (pt) * 1999-09-02 2007-03-30 Leadd Bv Proteína associada a apoptina
JP2003516152A (ja) * 1999-12-10 2003-05-13 レアト ベー．フェー． アポプチン会合タンパク質
US6593134B1 (en) 2000-03-10 2003-07-15 Cornell Research Foundation, Inc. Method of propagating chicken infectious anemia virus
CA2384357C (en) * 2000-07-10 2004-08-10 Yoshinori Tanaka Cleaning article
EP1199363A1 (de) * 2000-10-20 2002-04-24 Leadd B.V. Phosphorylationsmodifikationen von Apoptin
AUPR567401A0 (en) * 2001-06-14 2001-07-12 University Of Melbourne, The Circovirus vaccines
CA2477811A1 (en) * 2001-09-05 2003-03-13 Biomune Chicken anemia virus vaccine from cell line
US7566548B2 (en) * 2004-08-13 2009-07-28 University Of Massachusetts Methods for identifying therapeutic agents and for treating disease
CN102636646A (zh) * 2012-05-15 2012-08-15 扬州大学 快速检测禽白血病抗原的试纸条及其制备方法
EP3894569A2 (de) * 2018-12-12 2021-10-20 Flagship Pioneering Innovations V, Inc. Anellosome zur abgabe von therapeutischen proteinaustauschmodalitäten

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2042888B (en) 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
JPS6034925B2 (ja) 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法
JPS6032714A (ja) 1983-08-01 1985-02-19 Teijin Ltd 鼻腔粘膜に適用するための安定化された粉末状薬学的組成物
ATE66143T1 (de) 1985-01-11 1991-08-15 Abbott Lab Feste zubereitung mit langsamer freisetzung.
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5059587A (en) 1987-08-03 1991-10-22 Toyo Jozo Company, Ltd. Physiologically active peptide composition for nasal administration
GB8723846D0 (en) 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
US5079005A (en) 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
EP0434747B1 (de) * 1988-09-13 1999-05-19 Merial AUF DEM gB-PROTEIN DES MAREK'S DISEASE VIRUS (MDV) BASIERENDE, REKOMBINANTE IMPFSTOFFE
GB2237510B (en) 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5271961A (en) 1989-11-06 1993-12-21 Alkermes Controlled Therapeutics, Inc. Method for producing protein microspheres
ZA918426B (en) * 1990-10-31 1992-12-30 Akzo Nv Chicken anemia virus vaccine and diagnostic

Also Published As

Publication number Publication date
DE69131903D1 (de) 2000-02-17
IL99435A (en) 2006-10-31
AU8658091A (en) 1992-03-30
YU150891A (sh) 1995-10-24
DK0548234T3 (da) 2000-06-19
CA2091181A1 (en) 1992-03-13
HUT65974A (en) 1994-08-29
AU651999B2 (en) 1994-08-11
HU9300716D0 (en) 1993-06-28
DE69131903T2 (de) 2000-07-20
EP0905246A1 (de) 1999-03-31
UA48936C2 (uk) 2002-09-16
HRP940668B1 (en) 2000-10-31
ATE188739T1 (de) 2000-01-15
YU49095B (sh) 2003-12-31
US6319693B1 (en) 2001-11-20
JP2846116B2 (ja) 1999-01-13
MX9101042A (es) 1992-08-10
US6238669B1 (en) 2001-05-29
US5932476A (en) 1999-08-03
ZA917065B (en) 1992-05-27
RU2146292C1 (ru) 2000-03-10
US20020103336A1 (en) 2002-08-01
CA2091181C (en) 2006-02-21
IL99435A0 (en) 1992-08-18
SI9111508B (en) 2001-12-31
HRP940668A2 (en) 1997-12-31
JPH06504195A (ja) 1994-05-19
SI9111508A (sl) 1998-10-31
WO1992004446A1 (en) 1992-03-19
US5958424A (en) 1999-09-28
US6509446B2 (en) 2003-01-21
EP0548234A1 (de) 1993-06-30
ES2144399T3 (es) 2000-06-16
EP0548234B1 (de) 2000-01-12
GR3033173T3 (en) 2000-08-31
HU220102B (hu) 2001-10-28
US5491073A (en) 1996-02-13

Similar Documents

Publication Publication Date Title
Noteborn et al. Characterization of cloned chicken anemia virus DNA that contains all elements for the infectious replication cycle
US5491073A (en) Cloning of chicken anaemia DNA
RU2389506C2 (ru) Вакцина против рсv-2
AU703187B2 (en) Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
AU2002315560B2 (en) Attenuated circovirus
KR0183368B1 (ko) 페스트바이러스 뉴클레오티드 서열 및 폴리펩티드
AU2002315560A1 (en) Attenuated circovirus
US6217870B1 (en) Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1 VP2 and VP3 or sequences of that virus coding therefor
US20060073160A1 (en) Cloning of chicken anemia virus DNA
US20050100552A1 (en) Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
CA2402237A1 (en) Improved methods to isolate, identify, quantify, and propagate chicken infectious anemia virus and high titer vaccine
HK1020440A (en) Cloning of chicken anaemia dna
FR2741631A1 (fr) Adn recombinant codant pour les proteines de capside du parvovirus du canard

Legal Events

Date Code Title Description
A1B A search report has been drawn up
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: AESCULAAP B.V.

BV The patent application has lapsed